Together, our findings suggest that UCA1 may facilitate OXA resistance of HCC by miR‐138‐5p‐mediated the activation of the AKT/mTOR signaling and act as a potential therapeutic target for HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.